Verdence Capital Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.99M | Sell |
14,174
-1,778
| -11% | -$634K | 0.29% | 80 |
|
|
2025
Q4 | $5.22M | Sell |
15,952
-773
| -5% | -$245K | 0.31% | 72 |
|
|
2025
Q3 | $4.87M | Sell |
16,725
-227
| -1% | -$65.8K | 0.28% | 85 |
|
|
2025
Q2 | $4.73M | Buy |
16,952
+406
| +2% | +$115K | 0.32% | 75 |
|
|
2025
Q1 | $5.15M | Buy |
16,546
+1,507
| +10% | +$445K | 0.39% | 60 |
|
|
2024
Q4 | $3.92M | Buy |
15,039
+1,900
| +14% | +$564K | 0.32% | 76 |
|
|
2024
Q3 | $4.23M | Sell |
13,139
-813
| -6% | -$266K | 0.34% | 69 |
|
|
2024
Q2 | $4.36M | Buy |
13,952
+1,588
| +13% | +$467K | 0.39% | 60 |
|
|
2024
Q1 | $3.52M | Sell |
12,364
-559
| -4% | -$164K | 0.32% | 78 |
|
|
2023
Q4 | $3.72M | Sell |
12,923
-2,108
| -14% | -$574K | 0.36% | 67 |
|
|
2023
Q3 | $4.04M | Buy |
15,031
+3,293
| +28% | +$822K | 0.44% | 54 |
|
|
2023
Q2 | $2.61M | Buy |
11,738
+1,930
| +20% | +$448K | 0.3% | 89 |
|
|
2023
Q1 | $2.37M | Buy |
9,808
+1,824
| +23% | +$448K | 0.29% | 91 |
|
|
2022
Q4 | $2.1M | Sell |
7,984
-2,048
| -20% | -$549K | 0.26% | 98 |
|
|
2022
Q3 | $2.26M | Buy |
10,032
+1,222
| +14% | +$296K | 0.31% | 86 |
|
|
2022
Q2 | $2.14M | Sell |
8,810
-1,082
| -11% | -$265K | 0.28% | 96 |
|
|
2022
Q1 | $2.39M | Buy |
9,892
+1,043
| +12% | +$240K | 0.27% | 99 |
|
|
2021
Q4 | $1.99M | Buy |
8,849
+1,231
| +16% | +$260K | 0.23% | 103 |
|
|
2021
Q3 | $1.62M | Buy |
7,618
+2,668
| +54% | +$614K | 0.21% | 114 |
|
|
2021
Q2 | $1.21M | Buy |
4,950
+1,913
| +63% | +$471K | 0.17% | 140 |
|
|
2021
Q1 | $756K | Buy |
3,037
+319
| +12% | +$76.1K | 0.13% | 168 |
|
|
2020
Q4 | $625K | Sell |
2,718
-1,857
| -41% | -$428K | 0.12% | 182 |
|
|
2020
Q3 | $1.16M | Sell |
4,575
-2,444
| -35% | -$605K | 0.27% | 102 |
|
|
2020
Q2 | $1.66M | Sell |
7,019
-354
| -5% | -$80.8K | 0.41% | 71 |
|
|
2020
Q1 | $1.5M | Buy |
7,373
+842
| +13% | +$184K | 0.45% | 58 |
|
|
2019
Q4 | $1.57M | Buy |
6,531
+1,436
| +28% | +$317K | 0.39% | 73 |
|
|
2019
Q3 | $986K | Sell |
5,095
-796
| -14% | -$153K | 0.28% | 107 |
|
|
2019
Q2 | $1.09M | Sell |
5,891
-350
| -6% | -$62.7K | 0.31% | 93 |
|
|
2019
Q1 | $1.19M | Buy |
6,241
+890
| +17% | +$170K | 0.32% | 84 |
|
|
2018
Q4 | $1.04M | Buy |
5,351
+841
| +19% | +$164K | 0.29% | 79 |
|
|
2018
Q3 | $935K | Buy |
4,510
+2,647
| +142% | +$522K | 0.23% | 99 |
|
|
2018
Q2 | $344K | Buy |
1,863
+604
| +48% | +$107K | 0.08% | 200 |
|
|
2018
Q1 | $215K | Sell |
1,259
-193
| -13% | -$35.4K | 0.05% | 263 |
|
|
2017
Q4 | $252K | Buy |
+1,452
| New | +$257K | 0.06% | 236 |
|
Other funds holding AMGN
VCM
VPM
Verdence Capital Advisors's AMGN Position: Q1 2026 in Review
Verdence Capital Advisors reduced its Amgen (AMGN) stake by 11% in Q1 2026, selling an estimated $634K and leaving 14,174 shares worth $4.99M. The position accounts for 0.29% of the portfolio, ranked #80.
Verdence Capital Advisors first reported a position in AMGN in Q4 2017 and has held it in 34 quarters since. The position peaked at $5.22M in Q4 2025. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Verdence Capital Advisors held 14,174 shares of Amgen worth $4.99M as of Q1 2026.
- Verdence Capital Advisors sold 1,778 Amgen shares in Q1 2026, an estimated $634K.
- Amgen made up 0.29% of Verdence Capital Advisors's portfolio in Q1 2026, its #80 holding.
- Verdence Capital Advisors first reported a position in Amgen in Q4 2017 and has held it in 34 quarters since.
- Verdence Capital Advisors's Amgen position peaked at $5.22M in Q4 2025.
- 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Verdence Capital Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.